Samsara BioCapital, LLC - INSTIL BIO INC ownership

INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 63 filers reported holding INSTIL BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of INSTIL BIO INC
ValueSharesWeighting
Q2 2023$985,342
-16.6%
1,788,2800.0%0.17%
-29.1%
Q1 2023$1,181,695
+4.9%
1,788,2800.0%0.24%
+0.8%
Q4 2022$1,126,616
-87.0%
1,788,2800.0%0.24%
-88.0%
Q3 2022$8,655,000
+4.8%
1,788,2800.0%2.02%
-8.4%
Q2 2022$8,262,000
-61.4%
1,788,280
-10.2%
2.20%
-59.2%
Q1 2022$21,413,000
-37.2%
1,991,9500.0%5.39%
-18.5%
Q4 2021$34,082,000
-11.1%
1,991,950
-7.2%
6.61%
+9.9%
Q3 2021$38,349,000
-7.5%
2,145,3950.0%6.02%
+17.6%
Q2 2021$41,449,000
+6.3%
2,145,395
+38.1%
5.12%
-28.8%
Q1 2021$38,975,0001,554,0257.19%
Other shareholders
INSTIL BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Curative Ventures V LLC 37,980,073$16,255,471100.00%
CPMG Inc 8,218,467$3,517,5041.92%
Western Standard LLC 1,796,987$769,1100.70%
Vivo Capital, LLC 12,486,787$5,344,3450.59%
Nantahala Capital Management 1,000,000$428,0000.04%
Baker Brothers Advisors 4,704,395$2,013,4810.01%
HCR Wealth Advisors 40,000$17,1200.00%
Hennion & Walsh Asset Management, Inc. 98,080$41,9780.00%
Long Focus Capital Management, LLC 100,000$42,8000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 867,279$371,1950.00%
View complete list of INSTIL BIO INC shareholders